SCHEMBL13148486

SCHEMBL13148486

O=[PH]1Cc2ccccc2-c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.37
CES1 P23141 2/20 0.37
MAOB P27338 2/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 2/20 0.33
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
ADRA1D P25100 1/20 0.33
ADRA1A P35348 1/20 0.33
ADRA1B P35368 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP2A6 P11509 1/20 0.33
SRD5A2 P31213 2/20 0.32
SRD5A1 P18405 1/20 0.32
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30802110 1.00 MAOA (0.37) MAOACES1MAOBBCHEACHE
SCHEMBL31084212 0.68 TSHR (0.38) MAOACES1MAOBADRA1DADRA1A
SCHEMBL3925080 0.68 MEN1 (0.40) MAOACES1MAOBBCHEACHE
SCHEMBL19452869 0.66 MEN1 (0.43) MAOACES1MAOBBCHEACHE
SCHEMBL12614062 0.62 MAOA (0.42) MAOACES1MAOBBCHEKMT2A
Dihydrophenanthrene SCHEMBL30297028 0.61 CES1 (0.68) MAOACES1MAOBCYP2A6SRD5A2
Fluorene SCHEMBL31388525 0.61 MAOA (0.68) MAOACES1MAOBBCHEADRA1A
Fluorene SCHEMBL29478468 0.61 MAOA (0.68) MAOACES1MAOBBCHEADRA1A
Dihydrophenanthrene SCHEMBL155991 0.61 CES1 (0.68) MAOACES1MAOBCYP2A6SRD5A2
Fluorene SCHEMBL8180 0.61 MAOA (0.68) MAOACES1MAOBBCHEADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117683252-A Processing method of high-strength composite resin for processing air duct 江苏赛欧环保设备有限公司 2024-03-12 CN disclosed
CN-116515244-B Phosphorus-nitrogen composite modified epoxy resin and copper-clad plate prepared from same 江苏耀鸿电子有限公司 2024-01-23 CN disclosed
CN-116515244-B Phosphorus-nitrogen composite modified epoxy resin and copper-clad plate prepared from same 江苏耀鸿电子有限公司 2024-01-23 CN disclosed
CN-116515244-A Phosphorus-nitrogen composite modified epoxy resin and copper-clad plate prepared from same 江苏耀鸿电子有限公司 2023-08-01 CN disclosed
CN-116515244-A Phosphorus-nitrogen composite modified epoxy resin and copper-clad plate prepared from same 江苏耀鸿电子有限公司 2023-08-01 CN disclosed
US-20170349835-A1 Triazine-Intercalated Metal Phosphates, Compositions, and Methods HUBER CORP J M (US) 2017-12-07 US disclosed
US-20160046792-A1 FLAME RETARDANTS FROM RENEWABLE RESOURCES CENTRAL MICHIGAN UNIVERSITY 2016-02-18 US disclosed
US-20160046792-A1 FLAME RETARDANTS FROM RENEWABLE RESOURCES CENTRAL MICHIGAN UNIVERSITY 2016-02-18 US disclosed
US-20100233406-A1 Stabilized Blends of Polyester and Polyamide CIBA CORPORATION (US) 2010-09-16 US disclosed
US-20100233406-A1 Stabilized Blends of Polyester and Polyamide CIBA CORPORATION (US) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160046792-A1 FLAME RETARDANTS FROM RENEWABLE RESOURCES FABP4, FBL, PFKFB3 MAOA 2427/4885CES1 2912/4885MAOB 2932/4885
US-20170349835-A1 Triazine-Intercalated Metal Phosphates, Compositions, and Methods AP3M1, IPO4, HAX1 MAOA 2037/4885CES1 4864/4885MAOB 2302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.